Elevance Health Q3 GAAP EPS $6.68, adj. $7.53; revenue up 11.5%; raises FY2022 outlook

Elevance Health, Inc.

2022-Q3 EPS reported $20.86 revenue$116,666,000,000

GAAP net income $6.68/share vs $6.79 adjusted; adjusted EPS $7.53, up 10.9% YoY.
Operating revenue $39.6B (+11.5% YoY), driven by membership growth and premium rate increases.
Medical membership 47.3M, up 2.2M YoY (+4.9%), with growth in Medicaid, commercial fee-based, and Medicare Advantage.
FY2022 GAAP net income guidance raised to >$25.33/share; adjusted net income >$28.95/share.
Q4 dividend declared $1.28/share, payable Dec 21, 2022 to holders of record Dec 5.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.